Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.75%165.75B | 3.16%724.45B | 5.05%164.51B | 0.16%702.28B | 2.00%177.52B | -7.24%185.02B | 5.12%183.13B | 2.04%156.61B | 8.67%701.19B | 5.39%174.04B |
| Cost of revenue | 1.54%107.13B | 1.53%470.39B | 0.17%105.51B | 1.11%463.28B | -0.67%117.64B | -6.44%118.8B | 6.08%121.52B | 7.19%105.33B | 12.20%458.22B | 17.71%118.43B |
| Gross profit | -0.65%58.62B | 6.31%254.07B | 15.06%59B | -1.63%239B | 7.68%59.88B | -8.64%66.22B | 3.27%61.62B | -7.12%51.28B | 2.57%242.97B | -13.82%55.61B |
| Operating expense | 2.45%50.41B | 4.77%205.59B | 4.07%49.2B | 1.23%196.23B | -0.12%50.02B | -1.93%48.58B | 2.29%50.35B | 5.05%47.28B | 4.95%193.85B | -9.55%50.08B |
| Operating profit | -16.26%8.21B | 13.36%48.48B | 144.94%9.8B | -12.94%42.77B | 78.34%9.86B | -23.12%17.64B | 7.90%11.27B | -60.80%4B | -5.86%49.12B | -39.62%5.53B |
| Net non-operating interest income (expenses) | -85.20%29M | -35.58%563M | -21.29%196M | -28.65%874M | -9.42%298M | -68.22%164M | -25.23%163M | 53.70%249M | 93.22%1.23B | 108.23%329M |
| Non-operating interest income | -22.73%170M | -20.70%881M | -24.14%220M | -14.60%1.11B | -6.42%350M | -48.47%236M | -14.55%235M | 49.48%290M | 73.01%1.3B | 118.71%374M |
| Non-operating interest expense | 487.50%141M | 34.18%318M | -41.46%24M | 211.84%237M | 15.56%52M | 224.14%72M | 26.32%72M | 28.13%41M | -35.59%76M | 246.15%45M |
| Net investment income | -99.69%13M | -93.88%480M | -18.40%4.21B | 94.40%7.84B | 271.62%3.82B | 37.57%-3.12B | -27.67%1.98B | -2.12%5.16B | -20.55%4.03B | -56.84%1.03B |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 199.78%8.06B | 0 | 5,497.92%2.69B | 0 | 356M | 2.31B | -50.00%24M | -96.96%48M | 0 |
| Income from associates and other participating interests | 39.11%345M | 101.28%1.26B | 5.08%248M | -46.40%626M | -78.93%150M | -24.29%134M | -18.46%106M | 58.39%236M | 145.38%1.17B | 23.18%712M |
| Special income (charges) | -31.82%-145M | -3,465.88%-34.91B | 68.12%-110M | -124.29%-979M | 91.28%-241M | -101.40%-124M | 84.20%-269M | 3.90%-345M | 373.04%4.03B | -167.83%-2.76B |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 167.12%1.79B | 144.69%1.64B |
| Less:Other special charges | 31.82%145M | -16.45%818M | -68.12%110M | 116.83%979M | -78.62%241M | 101.39%124M | -83.47%269M | -3.90%345M | -820.82%-5.82B | 210.47%1.13B |
| Less:Write off | ---- | --34.09B | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 752.94%290M | 4.11%405M | 21.43%34M | 11.46%389M | -73.24%57M | 331.25%37M | 17.62%267M | 137.33%28M | 157.78%349M | 123.67%213M |
| Income before tax | -39.24%8.74B | -55.11%24.33B | 53.67%14.38B | -9.62%54.21B | 176.43%13.95B | -45.10%15.08B | 31.32%15.82B | -39.27%9.36B | 3.64%59.98B | -52.33%5.05B |
| Income tax | -57.17%2.35B | -27.81%11.81B | 54.44%5.49B | -13.43%16.36B | 42.95%3.02B | -38.68%5.01B | 23.59%4.77B | -25.18%3.56B | 9.89%18.89B | -26.62%2.11B |
| Net income | -28.16%6.39B | -66.91%12.52B | 53.18%8.89B | -7.86%37.85B | 272.71%10.93B | -47.83%10.07B | 34.97%11.05B | -45.55%5.8B | 1.00%41.08B | -61.95%2.93B |
| Net income continuous operations | -28.17%6.39B | -66.91%12.52B | 53.20%8.89B | -7.86%37.85B | 272.55%10.93B | -47.82%10.07B | 34.97%11.05B | -45.55%5.8B | 1.00%41.08B | -61.94%2.93B |
| Noncontrolling interests | -46.98%79M | -45.72%355M | 88.61%149M | -69.41%654M | -13.46%225M | -86.39%257M | 172.09%93M | -33.61%79M | 293.74%2.14B | 456.16%260M |
| Net income attributable to the company | -27.84%6.31B | -67.29%12.17B | 52.70%8.74B | -4.49%37.2B | 300.37%10.7B | -43.64%9.82B | 31.75%10.95B | -45.69%5.72B | -2.96%38.94B | -65.64%2.67B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -27.84%6.31B | -67.29%12.17B | 52.70%8.74B | -4.49%37.2B | 300.37%10.7B | -43.64%9.82B | 31.75%10.95B | -45.69%5.72B | -2.96%38.94B | -65.64%2.67B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -27.56%37.32 | -67.29%71.73 | 52.65%51.52 | -4.51%219.3 | 300.57%63.09 | -43.65%57.88 | 31.72%64.58 | -45.70%33.75 | -2.99%229.66 | -65.66%15.75 |
| Diluted earnings per share | -27.56%37.3 | -67.29%71.68 | 52.70%51.49 | -4.50%219.14 | 300.32%63.05 | -43.65%57.83 | 31.74%64.54 | -45.70%33.72 | -2.97%229.47 | -65.64%15.75 |
| Dividend per share | 0 | 0.00%100 | 0 | 0.00%100 | 0.00%50 | 0 | 0.00%50 | 0 | 11.11%100 | 0.00%50 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |